Getting My ABBV-744 BRD4 inhibitor clinical efficacy in refractory cancers To Work
In Segment A, participants will acquire unique doses and schedules of oral ABBV-744 tablet to determine Secure dosing program. Supplemental contributors might be enrolled with the recognized monotherapy dosign program. In Section B, contributors will get oral ruxolitinib and ABBV-744 might be presented as "incorporate-on" therapy. In Phase C, membe